photo
Speaker

John Glasspool

CHIEF EXECUTIVE OFFICER, ANTHOS THERAPEUTICS
Cambridge, Massachusetts, United States
John Glasspool is CEO, President and member of the Board of Directors of Anthos Therapeutics. He is also a member of the Board of Directors of Relmada Therapeutics Inc (Nasdaq: RLMD) and of Dalcor Corporation. Before joining Anthos Therapeutics, John held senior roles at Novartis including as the Global Head of the Cardiovascular and Metabolic Diseases franchise; Region Head for Europe; Global Head of Pricing & Market Access, as well as many other senior leadership roles. Before joining Anthos, John also held senior roles at Baxalta. John has served as a Member of the Board of BIO from 2014 to 2016, and is currently a Member of the Board, BIO Emerging Companies Section.
Speaking In
1:45 PM - 2:45 PM (PDT)
Tuesday, June 14
Hemostasis and thrombosis are believed to be so intricately linked that any strategies that reduce…